221 related articles for article (PubMed ID: 37644458)
1. Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants.
Gunadi ; Hakim MS; Wibawa H; Vujira KA; Puspitarani DA; Supriyati E; Trisnawati I; Iskandar K; Khair RE; Afiahayati ; Siswanto ; Puspadewi Y; Irianingsih SH; Nugrahaningsih DAA; Eryvinka LS; Utami FDT; Devana EM; Aditama L; Kinasih NCP; Hediningsih Y; Ananda NR; Marcellus ; Arguni E; Nuryastuti T; Wibawa T
BMC Med Genomics; 2023 Aug; 16(1):205. PubMed ID: 37644458
[TBL] [Abstract][Full Text] [Related]
2. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
3. Is the Infection of the SARS-CoV-2 Delta Variant Associated With the Outcomes of COVID-19 Patients?
Gunadi ; Hakim MS; Wibawa H; Marcellus ; Setiawaty V; Slamet ; Trisnawati I; Supriyati E; El Khair R; Iskandar K; Afiahayati ; Siswanto ; Irene ; Anggorowati N; Daniwijaya EW; Nugrahaningsih DAA; Puspadewi Y; Puspitarani DA; Tania I; Vujira KA; Ardlyamustaqim MB; Gabriela GC; Eryvinka LS; Nirmala BC; Geometri ET; Darutama AA; Kuswandani AA; Lestari ; Irianingsih SH; Khoiriyah S; Lestari I; Ananda NR; Arguni E; Nuryastuti T; Wibawa T
Front Med (Lausanne); 2021; 8():780611. PubMed ID: 34957154
[No Abstract] [Full Text] [Related]
4. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
BMJ; 2022 Mar; 376():e069761. PubMed ID: 35264324
[TBL] [Abstract][Full Text] [Related]
5. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
[TBL] [Abstract][Full Text] [Related]
6. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
medRxiv; 2022 Jan; ():. PubMed ID: 35118480
[TBL] [Abstract][Full Text] [Related]
7. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
8. Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
Mondi A; Mastrorosa I; Piselli P; Cimaglia C; Matusali G; Carletti F; Giannico G; Milozzi E; Biliotti E; Di Bari S; Chinello P; Beccacece A; Faraglia F; Vittozzi P; Mosti S; Tetaj N; Stazi GV; Pinnetti C; Camici M; D'Annunzio A; Marani A; Fabeni L; Specchiarello E; Gruber CEM; Villanacci A; Minicucci S; Garbuglia AR; Ianniello S; Marchioni L; Taglietti F; D'Offizi G; Palmieri F; Nicastri E; Maggi F; Vaia F; Girardi E; Antinori A
J Med Virol; 2023 Jun; 95(6):e28831. PubMed ID: 37246793
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients.
Deng H; Lin H; Mai Y; Liu H; Chen W
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):933-939. PubMed ID: 35482929
[TBL] [Abstract][Full Text] [Related]
10. A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study.
Li JX; Liao PL; Wei JC; Hsu SB; Yeh CJ
Front Public Health; 2023; 11():1143650. PubMed ID: 37799149
[TBL] [Abstract][Full Text] [Related]
11. Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.
Papagoras C; Zioga N; Papadopoulos V; Gerolymatou N; Kalavri E; Bounos C; Simopoulou T; Fragoulis GE; Panopoulos S; Fragiadaki K; Evangelatos G; Bournia VK; Arida A; Karamanakos A; Pappa M; Kravvariti E; Deftereou K; Kougkas N; Zampeli E; Kataxaki E; Melissaropoulos K; Barouta G; Panagiotopoulos A; Koutsianas C; Liossis SN; Georgiou P; Dimitroulas T; Tektonidou MG; Bogdanos DP; Elezoglou A; Voulgari PV; Sfikakis PP; Vassilopoulos D
Clin Rheumatol; 2023 Dec; 42(12):3375-3385. PubMed ID: 37731083
[TBL] [Abstract][Full Text] [Related]
12. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
13. Is Omicron really mild? - Comparative analysis of comorbidities and disease outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants.
Manchanda V; Mitra S; Rafique I; Sharma A; Dhakad MS; Saxena S; Kapoor S; Kumar S
Indian J Med Microbiol; 2023; 45():100391. PubMed ID: 37573055
[TBL] [Abstract][Full Text] [Related]
14. Comparative hospitalization risk for SARS-CoV-2 Omicron and Delta variant infections, by variant predominance periods and patient-level sequencing results, New York City, August 2021-January 2022.
Greene SK; Levin-Rector A; Kyaw NTT; Luoma E; Amin H; McGibbon E; Mathes RW; Ahuja SD
Influenza Other Respir Viruses; 2023 Jan; 17(1):e13062. PubMed ID: 36317297
[TBL] [Abstract][Full Text] [Related]
15. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant.
Sharma R; Zang W; Tabartehfarahani A; Lam A; Huang X; Sivakumar AD; Thota C; Yang S; Dickson RP; Sjoding MW; Bisco E; Mahmood CC; Diaz KM; Sautter N; Ansari S; Ward KR; Fan X
JAMA Netw Open; 2023 Feb; 6(2):e230982. PubMed ID: 36853606
[TBL] [Abstract][Full Text] [Related]
16. Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis.
Català M; Coma E; Alonso S; Andrés C; Blanco I; Antón A; Bordoy AE; Cardona PJ; Fina F; Martró E; Medina M; Mora N; Saludes V; Prats C; Prieto-Alhambra D; Alvarez-Lacalle E
Front Public Health; 2022; 10():961030. PubMed ID: 36033822
[TBL] [Abstract][Full Text] [Related]
17. Real life treatment experience and outcome of consecutively hospitalised patients with SARS-CoV-2 pneumonia by Omicron-1 vs Delta variants.
Giannitsioti E; Mavroudis P; Speggos I; Katsoulidou A; Pantazis N; Loupis T; Daniil I; Rekleiti N; Damianidou S; Louka C; Sidiropoulou C; Kranidiotis G; Velentza L; Stamati A; Kasidiaraki M; Efstratiadi E; Linardaki G; Chrysos G; Zarkotou O; Zoi K; Tryfinopoulou K; Gerakari S
Infect Dis (Lond); 2023 Oct; 55(10):706-715. PubMed ID: 37427461
[TBL] [Abstract][Full Text] [Related]
18. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection among patients with autoimmune rheumatic diseases; comparison between the Delta and Omicron waves in Israel.
Bieber A; Brikman S; Novack L; Ayalon S; Abu-Shakra M; Zeller L; Mader R; Sagy I
Semin Arthritis Rheum; 2023 Feb; 58():152129. PubMed ID: 36462304
[TBL] [Abstract][Full Text] [Related]
20. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
